Eli Lilly releases more data for new obesity drug, moving toward fast-track approval

·

·

Eli Lilly releases more data for new obesity drug, moving toward fast-track approval

Tirzepatide, marketed as Mounjaro for diabetes, showed even higher levels of weight loss: Participants had lost about 21% of their body weight, which was unprecedented. The drug is already approved as an injectable …
See Original Article

Smashing The Glass Ceiling: 7 Strategies For Women In Accounting – Forbes

CEO/Founder The Concierge CPA Consulting, and TaxPlanIQ, a SaaS Tax Planning Software for Accountants. Portrait of happy young woman in the city.
See Original Article

Lecturer in Accounting job with VICTORIA UNIVERSITY OF WELLINGTON | 338058

We also have accreditations with major professional accounting organisations, including Chartered Accountants Australia and New Zealand, CPA Australia
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.